VALPROATE DE SODIUM AGUETTANT 400 mg/4 ml, solution for injection 10 ampoules of 4 ml
Active ingredients: Sodium valproate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALPROATE DE SODIUM AGUETTANT 400 mg/4 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Aug 2007
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
67468312CIP73785757CIP133400937857574Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALPROATE DE SODIUMsolution | 400 mg · 4 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.